Archivio Italiano di Urologia e Andrologia最新文献

{"title":"Impact of laparoscopic experience on learning curves in robotic-assisted radical prostatectomy (RaRP): a comparative analysis of oncological and functional outcomes.","authors":"Pier Paolo Prontera, Francesca Romana Prusciano, Lattarulo Marco, Arman Tsaturyan, Carmine Sciorio, Francesco Dibenedetto, Lorenzo Romano, Francesco Saverio Grossi","doi":"10.4081/aiua.2025.13640","DOIUrl":"https://doi.org/10.4081/aiua.2025.13640","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to evaluate the influence of prior laparoscopic experience on the learning curve and surgical outcomes of robotic-assisted radical prostatectomy (RaRP).</p><p><strong>Methods: </strong>A retrospective analysis was performed on 101 patients treated between 2021 and 2023. Two surgeons at the beginning of their robotic learning curves were compared: one with extensive prior laparoscopic experience and the other without such a background. Perioperative, oncological, and functional outcomes were assessed, with a specific focus on Pentafecta criteria. Statistical analyses and cumulative sum (CUSUM) charts were employed to evaluate performance trends and surgical outcomes.</p><p><strong>Results: </strong>Surgeon A, with substantial prior laparoscopic expertise, demonstrated shorter operative times (p = 0.015), reduced intraoperative blood loss, and superior early functional outcomes. Specifically, patients operated on by Surgeon A exhibited higher pad-free continence rates and improved erectile function recovery at 12 months postoperatively (p < 0.01). Additionally, nerve-sparing procedures performed by Surgeon A showed a trend toward fewer positive surgical margins, although this difference did not reach statistical significance. CUSUM analysis revealed more stable and consistent performance trends for Surgeon A in achieving Pentafecta outcomes compared to Surgeon B.</p><p><strong>Conclusions: </strong>Previous laparoscopic experience significantly contributes to shortening the learning curve for RaRP and enhancing early functional outcomes. This advantage is likely attributable to greater surgical anatomical knowledge. These findings highlight the importance of tailored training programs and the potential for skill transfer between laparoscopic and robotic approaches. Further studies are warranted to refine surgical education strategies and improve patient care outcomes.</p>","PeriodicalId":46900,"journal":{"name":"Archivio Italiano di Urologia e Andrologia","volume":" ","pages":"13640"},"PeriodicalIF":1.4,"publicationDate":"2025-05-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144152292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Should magnetic resonance imaging be considered in every patient before a bladder outflow obstruction procedure?","authors":"Ivo Donkov, Nikolaos Chatzikrachtis, Abhisekh Chatterjee, Tevita Aho, Mark Emberton, Panagiotis Nikolinakos","doi":"10.4081/aiua.2025.13935","DOIUrl":"https://doi.org/10.4081/aiua.2025.13935","url":null,"abstract":"<p><p>To the Editor Benign prostatic hyperplasia (BPH) is a highly prevalent histological condition in aging men that can commonly cause lower urinary tract symptoms (LUTS) due to benign prostatic obstruction (BPO). BPH typically begins developing after the age of 40 and affects approximately 50-60% of men by age 60.....</p>","PeriodicalId":46900,"journal":{"name":"Archivio Italiano di Urologia e Andrologia","volume":" ","pages":"13935"},"PeriodicalIF":1.4,"publicationDate":"2025-05-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144152295","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Supratrigonal systectomy: last line treatment for radiation-induced hemorrhagic cystitis.","authors":"José Alberto Pereira, Duarte Vieira-Brito, Mário Lourenço, Paulo Conceição, Ricardo Godinho, Pedro Peralta, Bruno Jorge Pereira, Carlos Rabaça","doi":"10.4081/aiua.2025.13492","DOIUrl":"https://doi.org/10.4081/aiua.2025.13492","url":null,"abstract":"<p><strong>Introduction: </strong>Hemorrhagic cystitis is defined by the presence of hematuria, lower urinary tract symptoms and cystoscopy findings indicative of underlying urothelial damage. It is common in patients with prior radiotherapy for pelvic malignancies. The severity of the bleeding can vary from mild to severe hematuria refractory to conservative therapy and with a continuous need for transfusions. Treatment can be challenging not only by the lack of clear guidelines but also the multiple comorbidities of these patients. Urinary diversion with or without cystectomy should be reserved for those who have failed all the previously available therapy, because of the morbidity/mortality associated with this type of procedure. Supratrigonal cystectomy can be an option in patients with intense fibrosis of the pelvic region. The purpose of this article is to present the results of our institution with supratrigonal cystectomy with urinary diversion as a last line treatment for radiation-induced hemorrhagic cystitis.</p><p><strong>Materials and methods: </strong>We retrospectively analyzed 17 patients who underwent supratrigonal cystectomy and bladder mucosa fulguration with urinary diversion for refractory radiation-induced hemorrhagic cystitis in our institution from January 2010 to December 2020.</p><p><strong>Results and discussion: </strong>Median patient age at time of cystectomy was 69 years and 64.7% (11) were females. The most common etiology was prior radiation therapy for gynecologic malignancies (11-64.7%). All the patients had prior therapy with bladder irrigation and fulguration. Besides that, 29.4% (n=5) received intravesical therapy with formalin, 11.8% (n=2) hyperbaric oxygen therapy and 5.9% (n=1) prior urinary diversion. Median time between radiation therapy and cystectomy was 65 months. Median ASA score of 3, median preoperative hemoglobin was 9,6mg/dl and 10.5 mg/dl at time of discharge after surgery. Ileal conduit was used in 52.9% (9), cutaneous ureterostomy in 41.2% (7) and ureterosigmoidostomy in 5.9% (1). Majority of patients (10-58.8%) did not require any blood transfusion during surgery or during their stay. Clavien-Dindo complications grade III or higher occurred in 29,4% (5). Median hospital stay postoperative was 12 days. No mortality was reported in the 30 days after surgery. Median follow-up after cystectomy was 28 months, with a 1-year survival of 93.3% (14 of 15) and 3-year survival of 83.3% (10 of 13). There was no difference in the presence of postoperative complications or overall survival between the types of urinary diversion.</p><p><strong>Conclusions: </strong>This represents one of the largest series on cystectomy in hemorrhagic cystitis, that we found to this date. Supratrigonal cystectomy is a valid option as a last line treatment for radiation-induced hemorrhagic cystitis, reducing the risks associated with simple cystectomy in patients with prior pelvic radiation.</p>","PeriodicalId":46900,"journal":{"name":"Archivio Italiano di Urologia e Andrologia","volume":" ","pages":"13492"},"PeriodicalIF":1.4,"publicationDate":"2025-05-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144152296","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Extra-anatomical urinary diversion for malignant ureteric obstruction: our clinical experience.","authors":"Napoleon Moulavasilis, Konstantinos Douroumis, Konstantinos Kotrotsios, Periklis Anastasiou, Panagiotis Levis, Evangelos Fragkiadis, Ioannis Anastasiou","doi":"10.4081/aiua.2025.13869","DOIUrl":"https://doi.org/10.4081/aiua.2025.13869","url":null,"abstract":"<p><strong>Introduction and objectives: </strong>Ureteral stenosis and upper urinary tract obstruction present significant clinical challenges, especially in cases involving complex, long strictures. Traditional management options like ureteral stents and percutaneous nephrostomy tubes often result in complications and diminished quality of life. Extra-anatomical urinary diversion (EAUD) offers an alternative approach, particularly for oncologic patients requiring palliative care.</p><p><strong>Materials and methods: </strong>From 2015 to 2019, eight patients with cancer-related ureteral strictures underwent EAUD. In all patients cancer-specific prognosis exceeded one year. The procedure was performed using a standard surgical technique.</p><p><strong>Results: </strong>The mean patient age was 62.5 years, ranging from 22 to 82 years. The mean follow-up duration was 62.8 months. Improvement in renal function was observed in some patients, while the early complication rate was 62.5%. Notable complications included infections and encrustation of the prosthesis. Two patients experienced multiple infections of the overlying skin and soft tissue necessitated the dislodgement of the prothesis after 38 and 101 months, respectively.</p><p><strong>Conclusions: </strong>Extra-anatomical stent placement constitutes a somewhat effective and safe option in the context of complex ureteral obstruction management in oncologic patients. The lack of external devices and its longer duration without the need for substitution compared with conventional double J stents can theoretically assure a better quality of life. However, a careful patient selection is needed in order to maximize the patients' benefit.</p>","PeriodicalId":46900,"journal":{"name":"Archivio Italiano di Urologia e Andrologia","volume":" ","pages":"13869"},"PeriodicalIF":1.4,"publicationDate":"2025-05-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144152281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Recovery of functional outcomes after robot assisted radical prostatectomy (RaRP): impact of vacuum therapy compared to pde5 inhibitors alone.","authors":"Pier Paolo Prontera, Francesca Romana Prusciano, Marco Lattarulo, Arman Tsaturyan, Carmine Sciorio, Francesco Saverio Grossi","doi":"10.4081/aiua.2025.13639","DOIUrl":"https://doi.org/10.4081/aiua.2025.13639","url":null,"abstract":"<p><strong>Objective: </strong>This study evaluated the primary efficacy of vacuum therapy combined with phosphodiesterase type 5 inhibitors (PDE5i) vs. PDE5i alone in improving erectile function recovery, assessed via the International Index of Erectile Function (IIEF) questionnaire, after robotic-assisted radical prostatectomy (RARP). A secondary objective was to assess the impact of the combined therapy on continence outcomes, including pad usage and continence scores. The study also explored predictors of rehabilitation success and the potential synergistic effects of the combined approach.</p><p><strong>Materials and methods: </strong>A retrospective analysis of 101 patients who underwent RARP (2021-2023) was conducted. Patients were divided into Group 1 (PDE5i only, n=70) and Group 2 (PDE5i + vacuum therapy, n=31). Vacuum therapy was started within 20 days postoperatively and performed daily under specialist supervision. All data were completely anonymous. Primary outcomes included IIEF-5 scores for erectile function and continence recovery (pad usage, continence scores based on three levels: 0 - complete incontinence, 1 - stress incontinence and 2 - full continence). Predictive factors were analysed using repeated measures ANOVA and multivariate regression.</p><p><strong>Results: </strong>Group 2 showed significantly higher mean IIEF-5 scores at 12 months (10.2 vs. 2.5, p<0.001) and earlier continence recovery, with better scores at 3 and 6 months (p < 0.05). Vacuum therapy and PDE5i accelerate continence recovery during the early postoperative period, with fewer pads required, compared with patients treated with PDE5i alone, at 6 months (1.32 vs. 1.62; p=0.358) and 9 months (0.54 vs. 1.08; p=0.034). Key predictors of recovery included age, BMI, nervesparing status, and preoperative continence levels.</p><p><strong>Conclusions: </strong>This study demonstrates the benefits of combining vacuum therapy with PDE5i for improving erectile function and early continence recovery after RARP, highlighting the importance of early, individualized rehabilitation. Vacuum therapy enhances oxygenation, reduces fibrosis and complements PDE5i effects. Further research is needed to refine predictive factors for success and explore the impact of intraoperative blood loss on erectile recovery, enabling optimized, tailored strategies for post-RARP rehabilitation.</p>","PeriodicalId":46900,"journal":{"name":"Archivio Italiano di Urologia e Andrologia","volume":" ","pages":"13639"},"PeriodicalIF":1.4,"publicationDate":"2025-05-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144152294","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Serum ferritin, bone marrow iron and mortality rate in CKD patients with different methods of dialysis.","authors":"Mohammed Lateef Mohammed Alkhammasi, Bassam Muayad Alwan Al-Naqdi, Mina Muayad Alwan Al-Naqdi","doi":"10.4081/aiua.2025.13786","DOIUrl":"https://doi.org/10.4081/aiua.2025.13786","url":null,"abstract":"<p><strong>Background and aim: </strong>It is well recognized that one of the most significant public health concerns is chronic kidney disease (CKD). In a cohort of incident CKD patients without dialysis, or on hemodialysis (HD), or on peritoneal dialysis (PD), the complicated interactions between bone marrow iron, serum ferritin levels, and death rates were examined.</p><p><strong>Materials and methods: </strong>For this prospective and observational study, 288 CKD patients who were registered in three institutions between January 2022 and December 2023 were initially recruited. The final analysis comprised 200 patients, chosen based on predetermined inclusion and exclusion criteria.</p><p><strong>Results: </strong>The median age of all patients was 65.52 ± 8.36, with 102 patients (51%) being male. Of the patients followed up, forty (20%) died. Cardiovascular events accounted for 22.5% of deaths (9 patients), and infections accounted for 70% of deaths. An elevated ferritin level (HR 1.528, 95% CI 1.239-1.885, p < 0.001) and advanced age were important risk factors for infection-related cardiovascular disease.</p><p><strong>Conclusions: </strong>It was demonstrated that higher blood ferritin levels were substantially linked to a higher risk of death and that the most common causes of death of CKD patients in Iraq are infection-related.</p>","PeriodicalId":46900,"journal":{"name":"Archivio Italiano di Urologia e Andrologia","volume":" ","pages":"13786"},"PeriodicalIF":1.4,"publicationDate":"2025-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144102955","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Metastatic cancer to the penis: a multi-institutional comprehensive analysis of 31 patients.","authors":"Aldo Franco De Rose, Fabrizio Gallo, Francesca Ambrosini, Guglielmo Mantica, Tommaso Saccucci, Nataniele Piol, Bruno Spina, Franco Bertolotto, Carlo Ambruosi, Marco Ennas, Luca Timossi, Elisa Melani, Paola Baccini, Carlo Introini, Maurizio Schenone, Carlo Terrone","doi":"10.4081/aiua.2025.13848","DOIUrl":"https://doi.org/10.4081/aiua.2025.13848","url":null,"abstract":"<p><strong>Introduction: </strong>The metastatic spread of cancer to the penis is a very rare clinical entity generally associated with disseminated disease and poor prognosis. The aim of this paper was to show the outcomes of a series of patients treated for metastatic cancer to the penis and enhance the understanding and the management of penile metastasis in order to improve patients' care and outcomes.</p><p><strong>Methods: </strong>We retrospectively analyzed the medical records of 31 patients diagnosed with metastatic cancer to the penis and treated at eight Ligurian urological departments between January 2014 and January 2024. Clinical characteristics, physical examination findings, diagnostic evaluations, treatment options and follow-up data were assessed.</p><p><strong>Results: </strong>27 (87%) patients had a prior history of malignancy with a metachronous metastasis. The most common primary site of malignancy was the genitourinary tract (71.1%) followed by the gastrointestinal tract (16.1%). The time interval from the diagnosis of the primary tumour to the detection of the penile metastasis was 36.0 months. The penile metastasis generally appeared with a mass (54.8%) and pain (29%), more rarely with priapism (6.5%), oedema (6.5%) and hematuria/urinary disorders (3.2%). The metastatic lesion required a total penectomy in 17 (54.8%) patients and a partial penectomy in 8 patients (25.8%). At a follow-up of 15.9 (1-75) months, 4 (18.2%) patients were still alive with disease.</p><p><strong>Conclusions: </strong>Our data confirmed penile metastasis as a rare entity usually associated with clinical symptoms involving the penis in the context of a known primary malignancy, mainly from the neighboring pelvic organs, with a poor prognosis. The majority of our patients required a total penectomy with a negative impact on their quality of life. These aspects highlighted the importance of a penile examination and an early diagnosis of a penile metastasis during the follow-up schedule of many patients with a history of previous oncologic disease.</p>","PeriodicalId":46900,"journal":{"name":"Archivio Italiano di Urologia e Andrologia","volume":" ","pages":"13848"},"PeriodicalIF":1.4,"publicationDate":"2025-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144102953","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Sexual outcome of vasectomized patients: a systematic review.","authors":"Marshal Harvy Wicaksono, Ronald Sugianto, Gede Wirya Kusuma Duarsa","doi":"10.4081/aiua.2025.13644","DOIUrl":"https://doi.org/10.4081/aiua.2025.13644","url":null,"abstract":"<p><strong>Introduction: </strong>Vasectomy is one of the most effective ways of contraception. However, it still has various complications, including post-vasectomy sexual dysfunction. Some studies suggest that one of the sexual performance problems can be linked to psychological factors. However, other studies indicate that vasectomy can have positive effects on patient's sexual lives. Because of these conflicting findings, the purpose of this article is to examine the sexual outcome post-vasectomy using a systematic review of current studies.</p><p><strong>Methods: </strong>We performed the search using electronic databases MEDLINE, Pub Med, and Science Direct. We used \"vasectomy\", \"vasectomies\", and \"sexual outcome\", and \"sexual quality\" in the text keywords. Eleven studies, six case-control studies, and five cohorts met the inclusion criteria for this review.</p><p><strong>Results: </strong>Studies reported a significant improvement in IIEF scores, sexual desire, sexual satisfaction, and orgasm domain after vasectomy. However, a study found that low acceptance of vasectomy can lead to erectile dysfunction, and vasectomized men are slightly more likely to report problems in maintaining their erections.</p><p><strong>Conclusions: </strong>This systematic review shows that, although rare, there are complications after vasectomy. These complications can be related to decreased sexual function for patients after vasectomy. As a urologist, it is essential to offer adequate counseling to patients before vasectomy.</p>","PeriodicalId":46900,"journal":{"name":"Archivio Italiano di Urologia e Andrologia","volume":" ","pages":"13644"},"PeriodicalIF":1.4,"publicationDate":"2025-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144102956","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"What is the diagnostic process experience of patients with genital Lichen? An Italian Survey.","authors":"Stefano Lauretti, Michele Rizzo, Lorena Di Marco, Luca Braulin, Enzo Maria F Palminteri, Marco Bitelli, Muriel Rouffaneau, Tommaso Cai, Giovanni Liguori, Alessandro Palmieri","doi":"10.4081/aiua.2025.13379","DOIUrl":"https://doi.org/10.4081/aiua.2025.13379","url":null,"abstract":"<p><strong>Introduction: </strong>Genital Lichen Sclerosus (GLS) is a chronic inflammatory disease due to autoimmune events that occurs in anogenital region. It seems to affect mostly women but both the etiology and the prevalence of the disease are largely unknown. The aim of this cross-sectional study was to examine the real-world diagnostic and therapeutic experiences of patients with GLS, focusing on their perceptions and expectations regarding disease management.</p><p><strong>Methods: </strong>Utilizing Google Forms, we developed a questionnaire consisting of 10 items aimed at examining the diagnostic and therapeutic experiences of patients with GLS. This survey was distributed via email to all members of the Italian Association of Patients with Lichen Sclerosus (LISCLEA), which includes 564 female and 216 male members. The survey was accessible for a period of 48 hours in February 2020.</p><p><strong>Results: </strong>Of the 780 members surveyed, 280 (36.3% response rate) completed the questionnaire, comprising 226 females (80.7%), 53 males (18.9%), and 1 respondent (0.4%) who did not declared her/his gender identity. A significant 34% of respondents waited over five years for a correct diagnosis of GLS. Diagnostic challenges were frequently reported, with a majority (78%) believing that doctors' knowledge about LS is inadequate. Moreover, 63.9% expressed a need for better medical training concerning GLS, supported by calls for more research networks (42.5%) and specialized centers (26.1%). GLS had a severe impact on sexual health and relationships; 57.3% reported anxiety due to GLS, and 39% avoided intercourse because of symptoms like pain and discomfort. The majority (95%) received local treatments, while a small percentage (5%) underwent surgical interventions such as circumcision. The diagnostic and therapeutic process was perceived as difficult by most patients (82%).</p><p><strong>Conclusions: </strong>GLS profoundly affects patients' quality of life, causing significant anxiety, discomfort, and often hindering sexual activity. The study highlights the commonality of late diagnoses and the insufficient referral of patients to specialists, underscoring the need for greater awareness and expertise among healthcare providers. Enhancing doctor awareness and knowledge could facilitate earlier diagnosis and more effective management of GLS, thereby improving outcomes for those affected by this debilitating condition. This research advocates urgent enhancement in both medical education regarding GLS and the establishment of more specialized care pathways to better address the complexities of this disease.</p>","PeriodicalId":46900,"journal":{"name":"Archivio Italiano di Urologia e Andrologia","volume":" ","pages":"13379"},"PeriodicalIF":1.4,"publicationDate":"2025-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144101970","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Safety of large reservoirs in inflatable penile prosthesis surgery.","authors":"Ibrahim Alnadhari, Muammer Alshrani, Osama Abdeljaleel, Omar Ali, Abdulla Al-Ansari, Ahmad Shamsodini","doi":"10.4081/aiua.2025.13480","DOIUrl":"https://doi.org/10.4081/aiua.2025.13480","url":null,"abstract":"<p><strong>Introduction: </strong>The use of inflatable penile prostheses (IPP) has become a well-established treatment for erectile dysfunction, offering significant improvements in the quality of life for many patients. The reservoir site and size in IPP surgery are areas of ongoing research and debate. This study aims to evaluate the outcomes associated with the use of large reservoirs in IPP, focusing on both the surgical techniques and postoperative complications.</p><p><strong>Materials and methods: </strong>Our study is a retrospective study of 60 patients who underwent inflatable penile prosthesis (IPP) with large reservoir irrespective of the size of the prosthesis in Al Wakra Hospital from the period of 1st of January 2022 to 30th of August 2024.</p><p><strong>Results: </strong>Successful insertion of the large reservoir was carried out in all patients from the same penoscrotal incision. There was no recorded migration, urethral injury, infection, device failure, pain, erosion or LUTS in our patients. Revision was done in one patient.</p><p><strong>Conclusions: </strong>The use of large-volume reservoirs in inflatable penile prosthesis (IPP) surgery demonstrates a favorable safety profile, with no significant increase in complication rates compared to standard reservoir sizes.</p>","PeriodicalId":46900,"journal":{"name":"Archivio Italiano di Urologia e Andrologia","volume":" ","pages":"13480"},"PeriodicalIF":1.4,"publicationDate":"2025-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144102954","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}